A scFv targeting the N-terminal amino acids adjacent to the expanded polyglutamine of huntingtin protein was previously shown to successfully prevent protein aggregation46,47, underscoring the broad potential of this intrabody strategy for control of neurodegenerative diseases due to proteinopathy. This evidence concerns the gene HTT and proteostasis deficiencies.